- Home
- »
- Food Additives & Nutricosmetics
- »
-
Pyridoxine Market Size, Share, Growth, Industry Report 2033GVR Report cover
Pyridoxine Market (2026 - 2033) Size, Share & Trends Analysis Report By Product (Tablets, Capsules, Powders, Fortified Foods, Liquids), By Application (Furfuryl Alcohol, Solvent, Intermediate), By Source, By Region, And Segment Forecasts
- Report ID: GVR-4-68040-866-2
- Number of Report Pages: 84
- Format: PDF
- Historical Range: 2018 - 2024
- Forecast Period: 2026 - 2033
- Industry: Specialty & Chemicals
- Report Summary
- Table of Contents
- Segmentation
- Methodology
- Download FREE Sample
-
Download Sample Report
Pyridoxine Market Summary
The global pyridoxine market size was estimated at USD 284.0 million in 2025 and is projected to reach USD 439.8 million by 2033, growing at a CAGR of 5.6% from 2026 to 2033. The market growth is primarily driven by rising demand for dietary supplements and preventive healthcare, as consumers increasingly focus on micronutrient intake to support metabolic health, immunity, and neurological function.
Key Market Trends & Insights
- Asia Pacific the pyridoxine market with the largest revenue share of 29.6% in 2025.
- By product, liquids based pyridoxine segment is expected to witness the fastest growth of 8.0% from 2026 to 2033, in terms of value.
- By application, dietary supplements segment held the largest revenue share of 39.1% in 2025.
- By source, synthetic segment dominated the market with a revenue share of 82.6% in 2025.
Market Size & Forecast
- 2025 Market Size: USD 284.0 Million
- 2033 Projected Market Size: USD 439.8 Million
- CAGR (2026-2033): 5.6%
- Asia Pacific: Largest market in 2025
Vitamin B6 is widely used in supplements for energy metabolism, red blood cell formation, and nervous system support, making it a standard ingredient in multivitamin and B-complex formulations. Growth in aging populations and lifestyle-related deficiencies further reinforces baseline demand.Another major driver is the expansion of pharmaceutical applications, where pyridoxine is used both as an active ingredient and as an adjunct therapy. It is commonly prescribed to manage vitamin B6 deficiency, mitigate side effects of certain drug therapies, and support prenatal and neurological health. Increasing access to healthcare in emerging markets and rising pharmaceutical production volumes are supporting steady growth in this application segment.

Moreover, food fortification and functional nutrition trends are strengthening long-term market prospects. Governments and food manufacturers are increasingly incorporating vitamins into staple foods and beverages to address nutritional gaps. This is particularly evident in developing economies, where fortified foods offer a cost-effective way to improve population-level nutrition, supporting incremental growth in pyridoxine consumption beyond traditional supplement channels
Market Concentration & Characteristics
The pyridoxine market is moderately to highly concentrated, with a limited number of global manufacturers controlling a significant share of supply. Large players benefit from vertically integrated production, established synthesis technologies, and long-term supply agreements with pharmaceutical and nutraceutical companies. High capital requirements, regulatory compliance, and quality certification act as barriers to entry for new participants.

Competitive dynamics are shaped by cost efficiency, production scale, and regulatory approvals rather than product differentiation. While emerging producers particularly in Asia are expanding capacity, established manufacturers continue to dominate high-value pharmaceutical and food-grade segments. As demand grows for natural and specialty formulations, niche players may gain share, but overall market structure is expected to remain consolidated.
Product Insights
The tablets product accounted for a significant revenue share of 40.02% in 2025 in the global pyridoxine market, driven by widespread use in dietary supplements and pharmaceutical formulations, ease of dosage standardization, and long shelf life. Tablets remain the preferred format for OTC vitamins due to cost efficiency, stability, and established consumer acceptance.
The liquids, is expected to grow at the fastest CAGR of 8.0% during the forecast period, supported by increasing use in pediatric, geriatric, and clinical nutrition applications. Liquid formulations enable faster absorption and flexible dosing, making them suitable for medical and functional beverage applications.
Application Insights
Dietary Supplements segment dominated the market with the largest revenue share of 39.05% in 2025, due to high consumer awareness, routine multivitamin consumption, and growing focus on preventive health and wellness.
Food & Beverage segment is expected to grow fastest with a CAGR of 7.2% during the forecast period, driven by rising demand for fortified foods, functional drinks, and nutrition-enhanced staples. Regulatory support for micronutrient fortification in emerging markets is further accelerating adoption.
Source Insights
Synthetic continues to be the leading application segment, representing 82.6% share of the market in 2025. Its due to cost efficiency, consistent quality, and large-scale manufacturing capability that supports pharmaceutical and food applications.

Natural applications are emerging as the fastest-growing segment, projected to grow at a CAGR of 10.5% over the forecast period. This is supported by clean-label trends, consumer preference for plant-based ingredients, and increasing use in premium nutraceutical and functional food formulations.
Regional Insights
Asia Pacific pyridoxine market dominated the global market, accounting for a 29.6% value share in 2025, supported by expanding pharmaceutical manufacturing, rising dietary supplement consumption, and large-scale food fortification programs. Rapid urbanization and increasing health awareness are driving demand across China, India, and Southeast Asia. The region also benefits from strong local production capacity and cost-competitive manufacturing. As a result, Asia Pacific continues to gain share in global pyridoxine consumption.

China Pyridoxine Market Trends
Pyridoxine market in China held a dominant position in the region for being a major pyridoxine producer and consumer, supported by large-scale pharmaceutical manufacturing and food fortification initiatives. Domestic demand is driven by supplements, functional foods, and clinical nutrition. Strong local production capacity also positions China as a key supplier to global markets.
Europe Pyridoxine Market Trends
Europe’s pyridoxine market is shaped by strict regulatory standards and strong demand for fortified foods and pharmaceutical-grade vitamins. Adoption is supported by preventive healthcare policies and increasing focus on nutritional adequacy. While overall growth is moderate, demand for high-purity and traceable sources remains strong. Clean-label preferences are also influencing sourcing trends
Pyridoxine market in Germany represents a key European market, supported by pharmaceutical manufacturing strength and demand for fortified foods. Strict regulatory standards drive preference for high-quality, traceable pyridoxine sources. The country also acts as a distribution hub for vitamin ingredients across Europe.
North America Pyridoxine Market Trends
North America is a high-value market driven by mature dietary supplement consumption and advanced pharmaceutical usage. Strong consumer awareness of micronutrient benefits and well-established OTC distribution channels support stable demand. Regulatory clarity and emphasis on product quality favor standardized pyridoxine formulations. Growth is steady rather than rapid, reflecting market maturity
U.S. Pyridoxine Market Trends
The U.S. pyridoxine market is driven by high dietary supplement penetration and strong pharmaceutical demand. Consumer focus on wellness, energy metabolism, and neurological health supports steady consumption. Regulatory oversight ensures consistent quality and standardized formulations
Latin America Pyridoxine Market Trends
Latin America shows gradual growth in pyridoxine consumption, driven by improving healthcare access and expanding food fortification initiatives. Dietary supplements and pharmaceutical use are increasing, particularly in urban areas. However, economic volatility and uneven regulatory implementation limit faster market expansion. Brazil and Mexico remain key contributors
Middle East & Africa Pyridoxine Market Trends
The Middle East & Africa market remains relatively small but is steadily expanding with rising awareness of nutritional deficiencies and increasing imports of fortified foods and supplements. Demand is concentrated in urban centers and higher-income populations. Long-term growth potential exists as healthcare infrastructure and nutrition programs develop
Key Pyridoxine Company Insights
The global pyridoxine market is characterized by the presence of several leading players, including DSM, BASF SE, Tianxin Pharmaceuticals, Torrent Pharmaceuticals Ltd., Rochem International Inc., among others. These companies actively focus on research and development, capacity expansion, and strategic collaborations while prioritizing sustainability. They continuously adapt to shifting industry requirements, especially in sectors such as batteries, cosmetics, and pharmaceuticals, while ensuring compliance with regulations and optimizing supply chains to meet growing global demand efficiently and cost-effectively.
Key Pyridoxine Companies:
The following key companies have been profiled for this study on the pyridoxine market.
- DSM
- BASF SE
- Huazhong Pharmaceutical
- Tianxin Pharmaceutical
- Acebright Pharmaceuticals Group
- HuiSheng Pharma
- Xinfa Pharmaceutical
- Torrent Pharmaceuticals Ltd.
- Rochem International Inc.
Pyridoxine Market Report Scope
Report Attribute
Details
Market size value in 2026
USD 300.7 million
Revenue forecast in 2033
USD 439.8 million
Growth rate
CAGR of 5.6% from 2026 to 2033
Base year for estimation
2025
Historical data
2018 - 2024
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million/billion, Volume in kilotons, and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Product, application, source, region
Regional scope
North America; Europe; Asia Pacific; Middle East & Africa; Latin America
Country scope
U.S.; Canada; Mexico; Germany; France; Spain; Italy; UK; China; India; Japan; South Korea; Brazil; Argentina; South Africa; Saudi Arabia.
Key companies profiled
DSM; BASF SE; Huazhong Pharmaceutical; Tianxin Pharmaceutical; Acebright Pharmaceuticals Group; HuiSheng Pharma; Xinfa Pharmaceutical; Torrent Pharmaceuticals Ltd.; Rochem International Inc.
Customization scope
Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Pyridoxine Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2033. For this study, Grand View Research has segmented the global pyridoxine market report based on product, application, source, and region:

-
Product Outlook (Revenue, USD Million; Volume, Kilotons, 2018 - 2033)
-
Tablets
-
Capsules
-
Powders
-
Fortified Foods
-
Liquids
-
-
Application Outlook (Revenue, USD Million; Volume, Kilotons, 2018 - 2033)
-
Dietary Supplements
-
Pharmaceuticals
-
Food & Beverage
-
Cosmetics & Personal Care
-
Animal Feed
-
-
Source Outlook (Revenue, USD Million; Volume, Kilotons, 2018 - 2033)
-
Natural
-
Synthetic
-
-
Regional Outlook (Revenue, USD Million; Volume, Kilotons, 2018 - 2033)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
Germany
-
France
-
Spain
-
Italy
-
UK
-
-
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East & Africa
-
Saudi Arabia
-
South Africa
-
-
Frequently Asked Questions About This Report
b. The global pyridoxine market size was estimated at USD 284.0 million in 2025 and is expected to reach USD 300.7 million in 2026.
b. The global pyridoxine market is expected to grow at a compound annual growth rate of 5.6% from 2026 to 2033 to reach USD 439.8 million by 2033.
b. Asia Pacific dominated the global pyridoxine market, accounting for a 29.6% value share in 2025, supported by expanding pharmaceutical manufacturing, rising dietary supplement consumption, and large-scale food fortification programs. Rapid urbanization and increasing health awareness are driving demand across China, India, and Southeast Asia
b. Some key players operating the global pyridoxine market include DSM; BASF SE; Huazhong Pharmaceutical; Tianxin Pharmaceutical; Acebright Pharmaceuticals Group; HuiSheng Pharma; Xinfa Pharmaceutical; Torrent Pharmaceuticals Ltd.; and Rochem International Inc
b. Key factors that are driving the market growth include, rising demand for dietary supplements and preventive healthcare, as consumers increasingly focus on micronutrient intake to support metabolic health, immunity, and neurological function. Vitamin B6 is widely used in supplements for energy metabolism, red blood cell formation, and nervous system support, making it a standard ingredient in multivitamin and B-complex formulations.
Share this report with your colleague or friend.
Need a Tailored Report?
Customize this report to your needs — add regions, segments, or data points, with 20% free customization.
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
Trusted market insights - try a free sample
See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.